Tvardi Therapeutics (TVRD) FCF Margin Growth (1y) (2014 - 2025)
Tvardi Therapeutics (TVRD) FCF Margin Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 26,102.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 869.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 769.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 4,109.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 19,111.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 811.00 |
| 10 | Tvardi Therapeutics | 17.36 Mn | 17.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 116,623.00 |
| Dec 31, 2024 | 29,826.00 |
| Sep 30, 2024 | 10,317.00 |
| Jun 30, 2024 | 276,240.00 |
| Mar 31, 2024 | -90,400.00 |
| Dec 31, 2023 | 9,052.00 |
| Sep 30, 2023 | -17,074.00 |
| Jun 30, 2023 | -27,532.00 |
| Mar 31, 2023 | -2,775.00 |
| Dec 31, 2022 | -56,930.00 |
| Sep 30, 2022 | -16,335.00 |
| Mar 31, 2022 | 69,211.00 |
| Dec 31, 2021 | -22,508.00 |
| Sep 30, 2021 | 16,369.00 |
| Mar 31, 2021 | -75,261.00 |
| Sep 30, 2020 | 27,449.00 |
| Jun 30, 2020 | -26,167.00 |
| Mar 31, 2020 | 15,513.00 |
| Sep 30, 2019 | -10,244.00 |
| Jun 30, 2019 | -165,575.00 |